XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 8 - Segment Information (Details) - Operating Segment Information (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Segment Reporting Information [Line Items]        
Revenues $ 18,540 $ 12,676 $ 34,940 $ 23,894
Gross profit 11,123 7,600 20,828 14,397
Selling expenses 1,342 1,419 3,405 2,502
9,781 6,181 17,423 11,895
Reconciling items (5,038) [1] (3,243) [1] (9,787) [1] (5,942) [1]
Earnings before income taxes 4,743 2,938 7,636 5,953
Biological Indicators [Member]
       
Segment Reporting Information [Line Items]        
Revenues 6,441 6,010 12,858 10,864
Gross profit 4,051 3,482 7,835 6,043
Selling expenses 368 556 772 946
3,683 2,926 7,063 5,097
Instruments [Member]
       
Segment Reporting Information [Line Items]        
Revenues 9,065 6,666 16,750 13,030
Gross profit 5,455 4,118 10,382 8,354
Selling expenses 829 863 1,821 1,556
4,626 3,255 8,561 6,798
Continuous Monitoring [Member]
       
Segment Reporting Information [Line Items]        
Revenues 3,034   5,332  
Gross profit 1,617   2,611  
Selling expenses 145   812  
$ 1,472   $ 1,799  
[1] Reconciling items include general and administrative, research and development, and other expenses.